|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Stabilization of aqueous nanoscale zerovalcnt iron dispersions by anionic polyelectrolytes: adsorbed anionic polyeleotrolyte layer properties and their effect on aggregafion and sedimentation 显示文摘 | Tanapon P Navid S Kevin S | 2008 | Journal of Nanoparticle Research2008，10，5： | 1 |
| 2 | Ionic strength and composition affect the mobility of surface-modified Fe^0 nanoparticles in water-saturated sand columns 显示文摘 | Navid S Hye-jin K Tanapon P | 2008 | Environmental Science & Technology2008，42，9： | 1 |
| 3 | Aggregation kinetics of multiwalled carbon nanotubes in aquatic systems: measurements and environmental implications 显示文摘 | Navid B S Lisa D P | 2008 | Environ Sci Technol2008，42，21： | 1 |
| 4 | Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences 显示文摘 | Navid S Judy P Michael A | 2013 | Journal of hyperten- sion2013，31，1： | 1 |
| 5 | Modeling of fluidized bed reactor of ethylene polymerization显示文摘 | Navid M Saeed P | 2004 | Chemical Engineering Journal2004，，97： | 1 |
| 6 | A real- time mathematical computer method for potato inspection usingmachine vision 显示文摘 | Navid Razmjooy B Somayeh Mousavi P Soleymani | 2012 | Computers- Mathematics with Applica- tions2012，63，1： | 1 |
| 7 | A study on vibration of stewart platform-based machine tool table 显示文摘 | Siamak P Mehran M Navid K | 2013 | The International JournalofAdvanced ManufacturingTechnology(S0268-3768)2013，65，5： | 1 |
| 8 | Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences 显示文摘 | Navid S Judy P Michael A | 2013 | Journal of Hypertension2013，31，1： | 1 |
| 9 | New procedure for optimal design and evalu- ation of cogeneration system based on advanced exer- goeconomic and exergoenvironmental analysis显示文摘 | MANESH M H K NAVID P MARIGORTA A M B | 2013 | En- ergy2013，59，： | 1 |
| 10 | Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastases显示文摘AIM To investigate rates of distant metastases(DM) detected with [18]fluorodeoxyglucose-positron emissiontomography/computed tomography(^(18)FDG-PET/CT) in early stage invasive breast cancer.METHODS We searched the English language literature databases of PubM ed, EMBASE, ISI Web of Knowledge, Web of Science and Google Scholar, for publications on DM detected in patients who had ^(18)FDG-PET/CT scans as part of the staging for early stages of breast cancer(stage Ⅰ?and Ⅱ), prior to or immediately following surgery. Reports published between 2011 and 2017 were considered. The systematic review was conducted according to the PRISMA guidelines.RESULTS Among the 18 total studies included in the analysis, the risk of DM ranged from 0% to 8.3% and 0% to 12.9% for stage Ⅰ?and Ⅱ invasive breast cancer, respectively. Among the patients with clinical stage Ⅱ, the rate of occult metastases diagnosed by ^(18)FDG-PET/CT was 7.2%(range, 0%-19.6%) for stage ⅡA and 15.8%(range, 0%-40.8%) for stage ⅡB. In young patients(< 40-yearold), ^(18)FDG-PET/CT demonstrated a higher prevalence of DM at the time of diagnosis for those with aggressive histology(i.e., triple-negative receptors and poorly differentiated grade).CONCLUSION Young patients with poorly differentiated tumors and stage ⅡB triple-negative breast cancer may benefit from ^(18)FDG-PET/CT at initial staging to detect occult DM prior to surgery. | Vincent Vinh-Hung Hendrik Everaert Karim Farid Navid Djassemi Jacqueline Baudin-Veronique Stefanos Bougas Yuriy Michailovich Clarisse Joachim-Contaret Elsa Cécilia-Joseph Claire Verschraegen Nam P Nguyen | 2017 | World Journal of Radiology2017，9，7： | 0 |
| 11 | Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis显示文摘BACKGROUND The prognostic value of preoperative fluorine-18-fluorodeoxyglucose positronemission tomography(18 F-FDG PET)scan for determining overall survival(OS)in breast cancer(BC)patients is controversial.AIM To evaluate the OS predictive value of preoperative PET positivity after 15 years.METHODS We performed a retrospective search of the Universitair Ziekenhuis Brussel patient database for nonmetastatic patients who underwent preoperative PET between 2002-2008.PET positivity was determined by anatomical region of interest(AROI)findings for breast and axillary,sternal,and distant sites.The prognostic role of PET was examined as a qualitative binary factor(positive vs negative status)and as a continuous variable[maximum standard uptake value(SUVmax)]in multivariate survival analyses using Cox proportional hazards models.Among the 104 identified patients who received PET,36 were further analyzed for the SUVmax in the AROI.RESULTS Poor OS within the 15-year study period was predicted by PET-positive status for axillary(P=0.033),sternal(P=0.033),and combined PET-axillary/sternal(P=0.008)nodes.Poor disease-free survival was associated with PET-positive axillary status(P=0.040)and combined axillary/sternal status(P=0.023).Cox models confirmed the long-term prognostic value of combined PETaxillary/sternal status[hazard ratio(HR):3.08,95%confidence interval:1.42-6.69].SUVmax of ipsilateral breast and axilla as continuous covariates were significant predictors of long-term OS with HRs of 1.25(P=0.048)and 1.54(P=0.029),corresponding to relative increase in the risk of death of 25%and 54%per SUVmax unit,respectively.In addition,the ratio of the ipsilateral axillary SUVmax over the contralateral axillary SUVmax was the most significant OS predictor(P=0.027),with 1.94 HR,indicating a two-fold relative increase of mortality risk.CONCLUSION Preoperative PET is valuable for prediction of long-term survival.Ipsilateral axillary SUVmax ratio over the uninvolved side represents a new prognostic finding that warrants further investigation. | Justine Perrin Karim Farid Hilde Van Parijs Olena Gorobets Vincent Vinh-Hung Nam P Nguyen Navid Djassemi Mark De Ridder Hendrik Everaert | 2022 | World Journal of Clinical Oncology2022，13，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员